Wilsons Equity Research has released an updated analysis on Hexima Limited, with a view on the potential for success in phase II. Wilsons maintains its OVERWEIGHT rating and a $0.75 12-month price target.
View the full report (pdf)
Wilsons Updated Research Report
Home » Company News »